Anticancer therapeutic potential of soy isoflavone, genistein.

@article{Ravindranath2004AnticancerTP,
  title={Anticancer therapeutic potential of soy isoflavone, genistein.},
  author={Mepur H Ravindranath and Sakunthala Muthugounder and Naftali Presser and S. Viswanathan},
  journal={Advances in experimental medicine and biology},
  year={2004},
  volume={546},
  pages={
          121-65
        }
}
Genistein (4'5, 7-trihydroxyisoflavone) occurs as a glycoside (genistin) in the plant family Leguminosae, which includes the soybean (Glycine max). A significant correlation between the serum/plasma level of genistein and the incidence of gender-based cancers in Asian, European and American populations suggests that genistein may reduce the risk of tumor formation. Other evidence includes the mechanism of action of genistein in normal and cancer cells. Genistein inhibits protein tyrosine kinase… Expand
Multi-targeted therapy of cancer by genistein.
TLDR
Both in vivo and in vitro studies have clearly shown that genistein, one of the major soy isoflavones is a promising agent for cancer chemoprevention and further suggest that it could be an adjunct to cancer therapy by virtue of its effects on reversing radioresistance and chemoresistance. Expand
An insight on genistein as potential pharmacological and therapeutic agent
TLDR
Evidence showed that geinstein increases osteoblasts formation as well as decreases osteoclast production, which proves the potentiality of phytoestrogens as a source of bioactive substance. Expand
Evidence for genistein as a mitochondriotropic molecule.
TLDR
A pharmacologically relevant issue due to the possibility of using genistein as a mitochondria-targeted drug in cases of cancer, neurodegeneration, cardiovascular, and endocrine disease, is discussed. Expand
Evidence for genistein as a mitochondriotropic molecule.
TLDR
A pharmacologically relevant issue due to the possibility of using genistein as a mitochondria-targeted drug in cases of cancer, neurodegeneration, cardiovascular, and endocrine disease, is discussed. Expand
Synergistic effects of protein tyrosine kinase inhibitor genistein with camptothecins against three cell lines in vitro.
TLDR
Abrogation of the G2/M checkpoint control by genistein may be a useful maneuver to increase cytotoxicity of agents that damage DNA and inhibit cell-cycle progression in the G 2/M boundary. Expand
Soy-derived Isoflavones Inhibit HeLa Cell Growth by Inducing Apoptosis
TLDR
It is proposed that natural soy-derived isoflavones are potential candidates as chemoterapeutic agents against human cervical cancer through inducing apoptosis via the mitochondrial pathway and comparisons with reported data indicated that synergistic effect existed between the is oflavone species contained in SI-I. Expand
Puma is a novel target of soy isoflavone genistein but is dispensable for genistein-induced cell fate determination.
TLDR
The results raise a concern that molecular targets identified by powerful omic approaches may not necessarily represent key molecules responsible for given cellular phenotypes and thus must be verified by conclusive assays. Expand
Genistein induces a protective immunomodulatory effect in a mouse model of cervical cancer.
TLDR
It is demonstrated that genistein exerts an immunomodulatory effect in a mouse model of Human Papillomavirus (HPV) associated-cervical cancer. Expand
Genistein: A multipurpose isoflavone
TLDR
Among various soya isoflavones, genistein has been shown to have a wide range of activities in animal models and experimental studies, and its anticancer, lipid lowering, anti-diabetic, antiradiation, against eye diseases, against photodamage, against obesity and as well as immune system enhancers or stimulants have been heeded upon in the scientific world. Expand
The Daidzein Metabolite, 6,7,4'-Trihydroxyisoflavone, Is a Novel Inhibitor of PKCα in Suppressing Solar UV-Induced Matrix Metalloproteinase 1
TLDR
The inhibitory effect of 6,7,4'-THIF on sUV-induced MMPs is elucidated and suggest PKCα as its direct molecular target. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 255 REFERENCES
Effects of genistein and daidzein on membrane characteristics of HCT cells.
TLDR
Genistein and daidzein could reduce the density of cell surface charge and increase the order of membrane protein conformation, which may represent one of the mechanisms of the effect of isoflavonoids on growth inhibition, differentiation promotion, and transfer interference in a tumor cell line. Expand
Effects of genistein and synergistic action in combination with eicosapentaenoic acid on the growth of breast cancer cell lines
TLDR
Dietary intake of genistein in combination with EPA may be beneficial for breast cancer control and dose- and time-dependent in vitro growth inhibition at high concentrations, as well as synergism with eicosapentaenoic acid. Expand
Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC‐3
Genistein is a major component of soybean isoflavone and has multiple functions resulting in antitumor effects. Prostate cancer is 1 of the targets for the preventive role of genistein. We examinedExpand
Anticancer activity of genistein-piperazine complex. In vitro study with HL-60 cells.
TLDR
The measured anticancer effects of GP and genistein were qualitatively and quantitatively similar, indicating thatgenistein-amine complex does not loose the activity of the parent compound. Expand
Genistein Inhibits Nonoxidative Ribose Synthesis in MIA Pancreatic Adenocarcinoma Cells: A New Mechanism of Controlling Tumor Growth
TLDR
It is demonstrated that genistein controls tumor growth primarily through the regulation of glucose metabolism, specifically targeting glucose carbon incorporation into nucleic acid ribose through the nonoxidative steps of the pentose cycle, which represents a new paradigm for the antiproliferative action of a plant phytochemical. Expand
Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract.
TLDR
The results suggest that two of isoflavone derivatives, biochanin A and genistein, inhibit the cell growth of stomach cancer cell lines in vitro through activation of a signal transduction pathway for apoptosis, and in vivo experiments demonstrate that biochan in A can be used as an anticancer agent. Expand
Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity.
TLDR
Genistein is identified as a potential therapeutic agent for PCa and as a tool with which to study the control of apoptosis in PCa, and an in vivo growth inhibitory role by genistein consumed in quantities associated with a soy-based diet is investigated. Expand
Influence of genistein (4',5,7-trihydroxyisoflavone) on the growth and proliferation of testicular cell lines.
TLDR
Genistein-induced apoptosis identifies genistein as a potential diagnostic and therapeutic tool in testicular pathophysiological research. Expand
Genistein exerts multiple suppressive effects on human breast carcinoma cells.
TLDR
In vitro and in vivo studies demonstrate that genistein exerts multiple suppressive effects on breast carcinoma cells, suggesting that its mechanism of chemoprevention is pleiotropic. Expand
Synergistic Effect of Genistein and BCNU on Growth Inhibition and Cytotoxicity of Glioblastoma Cells
TLDR
Results indicate that genistein at typical adult dietary plasma levels can significantly enhance the antiproliferative and cytotoxic action of BCNU. Expand
...
1
2
3
4
5
...